XFOR US Equity

X4 Pharmaceuticals, Inc

Health Care · Biological Products, (No Diagnostic Substances) · CIK 1501697 · FY ends Dec 31

$4.16

-0.05 (-1.19%)

USD · as of 2026-08-19 · marketstack

Switch Ticker

Events

0 8-K filings · 0 13D · 3 13G

Date

Event

What happened / filer

Source

2026-08-14

13G/A

Schedule 13G amendment — ≥5% beneficial owner (passive) · by PERCEPTIVE ADVISORS LLC

2026-08-14

13G/A

Schedule 13G amendment — ≥5% beneficial owner (passive) · by Deep Track Capital, LP

2026-07-30

13G

Schedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.

Source: SEC EDGAR (public domain) · history starts 2026-07-30

Every row is a filed document, checked against its EDGAR index.